Three Methods for 18F Labeling of the HER2-Binding Affibody Molecule ZHER2:2891 Including Preclinical Assessment

Journal of Nuclear Medicine - China
doi 10.2967/jnumed.113.122465
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Society of Nuclear Medicine

Related search

Preclinical Evaluation of 99mTc Direct Labeling ZHER2:V2 for HER2 Positive Tumors Imaging

Oncology Letters
Cancer ResearchOncology
2018English

Adenovirus 5 Vector Genetically Re-Targeted by an Affibody Molecule With Specificity for Tumor Antigen HER2/neu

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2007English

Labelling Chemistry and Characterization of [90y/177Lu]-Dota-Zher2:342-3 Affibody Molecule, a Candidate Agent for Locoregional Treatment of Urinary Bladder Carcinoma

International Journal of Molecular Medicine
MedicineGenetics
2007English

Biodistribution and Radiation Dosimetry of the Anti-Her2 Affibody Molecule 68Ga-Aby-025 in Breast Cancer Patients

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2016English

HER2-Positive Tumors Imaged Within 1 Hour Using a Site-Specifically 11c-Labeled Sel-Tagged Affibody Molecule

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2012English

Thiol-Reactive PODS-Bearing Bifunctional Chelators for the Development of EGFR-Targeting [18F]AlF-Affibody Conjugates

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2020English

Small Molecule Interactome Mapping by Photoaffinity Labeling Reveals Binding Site Hotspots for the NSAIDs

English

18f-Labeling Using Click Cycloadditions

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2014English

In Vivo Targeting of HER2-positive Tumor Using 2-Helix Affibody Molecules

Amino Acids
Organic ChemistryBiochemistryClinical Biochemistry
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy